Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure

NCT00462774 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

German Heart Institute

Collaborators